Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer

Despite optimal radiation therapy (RT), chemotherapy and/or surgery, a majority of patients with locally advanced non-small cell lung cancer (NSCLC) fail treatment. To identify novel gene targets for improved tumor control, we performed whole genome RNAi screens to identify knockdowns that most repr...

Full description

Bibliographic Details
Main Authors: Cron, Kyle R., Zhu, Kaya, Kushwaha, Deepa S., Hsieh, Grace, Merzon, Dmitry, Rameseder, Jonathan, Chen, Clark C., D'Andrea, Alan D., Kozono, David
Other Authors: Massachusetts Institute of Technology. Computational and Systems Biology Program
Format: Article
Language:en_US
Published: Public Library of Science 2013
Online Access:http://hdl.handle.net/1721.1/81218
_version_ 1826210548827553792
author Cron, Kyle R.
Zhu, Kaya
Kushwaha, Deepa S.
Hsieh, Grace
Merzon, Dmitry
Rameseder, Jonathan
Chen, Clark C.
D'Andrea, Alan D.
Kozono, David
author2 Massachusetts Institute of Technology. Computational and Systems Biology Program
author_facet Massachusetts Institute of Technology. Computational and Systems Biology Program
Cron, Kyle R.
Zhu, Kaya
Kushwaha, Deepa S.
Hsieh, Grace
Merzon, Dmitry
Rameseder, Jonathan
Chen, Clark C.
D'Andrea, Alan D.
Kozono, David
author_sort Cron, Kyle R.
collection MIT
description Despite optimal radiation therapy (RT), chemotherapy and/or surgery, a majority of patients with locally advanced non-small cell lung cancer (NSCLC) fail treatment. To identify novel gene targets for improved tumor control, we performed whole genome RNAi screens to identify knockdowns that most reproducibly increase NSCLC cytotoxicity. These screens identified several proteasome subunits among top hits, including the topmost hit PSMA1, a component of the core 20 S proteasome. Radiation and proteasome inhibition showed synergistic effects. Proteasome inhibition resulted in an 80–90% decrease in homologous recombination (HR), a 50% decrease in expression of NF-κB-inducible HR genes BRCA1 and FANCD2, and a reduction of BRCA1, FANCD2 and RAD51 ionizing radiation-induced foci. IκBα RNAi knockdown rescued NSCLC radioresistance. Irradiation of mice with NCI-H460 xenografts after inducible PSMA1 shRNA knockdown markedly increased murine survival compared to either treatment alone. Proteasome inhibition is a promising strategy for NSCLC radiosensitization via inhibition of NF-κB-mediated expression of Fanconi Anemia/HR DNA repair genes.
first_indexed 2024-09-23T14:51:44Z
format Article
id mit-1721.1/81218
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T14:51:44Z
publishDate 2013
publisher Public Library of Science
record_format dspace
spelling mit-1721.1/812182022-10-01T22:58:40Z Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer Cron, Kyle R. Zhu, Kaya Kushwaha, Deepa S. Hsieh, Grace Merzon, Dmitry Rameseder, Jonathan Chen, Clark C. D'Andrea, Alan D. Kozono, David Massachusetts Institute of Technology. Computational and Systems Biology Program Rameseder, Jonathan Despite optimal radiation therapy (RT), chemotherapy and/or surgery, a majority of patients with locally advanced non-small cell lung cancer (NSCLC) fail treatment. To identify novel gene targets for improved tumor control, we performed whole genome RNAi screens to identify knockdowns that most reproducibly increase NSCLC cytotoxicity. These screens identified several proteasome subunits among top hits, including the topmost hit PSMA1, a component of the core 20 S proteasome. Radiation and proteasome inhibition showed synergistic effects. Proteasome inhibition resulted in an 80–90% decrease in homologous recombination (HR), a 50% decrease in expression of NF-κB-inducible HR genes BRCA1 and FANCD2, and a reduction of BRCA1, FANCD2 and RAD51 ionizing radiation-induced foci. IκBα RNAi knockdown rescued NSCLC radioresistance. Irradiation of mice with NCI-H460 xenografts after inducible PSMA1 shRNA knockdown markedly increased murine survival compared to either treatment alone. Proteasome inhibition is a promising strategy for NSCLC radiosensitization via inhibition of NF-κB-mediated expression of Fanconi Anemia/HR DNA repair genes. American Society for Radiation Oncology (Junior Faculty Career Research Training Award) Harvard University. Joint Center for Radiation Therapy (Foundation Grant) Dana-Farber/Harvard Cancer Center (SPORE Developmental Research Project Award in Lung Cancer Research) National Cancer Institute (U.S.) (Award K08CA172354) 2013-09-27T16:19:53Z 2013-09-27T16:19:53Z 2013-09 2013-04 Article http://purl.org/eprint/type/JournalArticle 1932-6203 http://hdl.handle.net/1721.1/81218 Cron, Kyle R., Kaya Zhu, Deepa S. Kushwaha, Grace Hsieh, Dmitry Merzon, Jonathan Rameseder, Clark C. Chen, Alan D. D’Andrea, and David Kozono. “Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer.” Edited by A. R. M. Ruhul Amin. PLoS ONE 8, no. 9 (September 5, 2013): e73710. en_US http://dx.doi.org/10.1371/journal.pone.0073710 PLoS ONE Creative Commons Attribution http://creativecommons.org/licenses/by/2.5/ application/pdf Public Library of Science PLoS
spellingShingle Cron, Kyle R.
Zhu, Kaya
Kushwaha, Deepa S.
Hsieh, Grace
Merzon, Dmitry
Rameseder, Jonathan
Chen, Clark C.
D'Andrea, Alan D.
Kozono, David
Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer
title Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer
title_full Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer
title_fullStr Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer
title_full_unstemmed Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer
title_short Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer
title_sort proteasome inhibitors block dna repair and radiosensitize non small cell lung cancer
url http://hdl.handle.net/1721.1/81218
work_keys_str_mv AT cronkyler proteasomeinhibitorsblockdnarepairandradiosensitizenonsmallcelllungcancer
AT zhukaya proteasomeinhibitorsblockdnarepairandradiosensitizenonsmallcelllungcancer
AT kushwahadeepas proteasomeinhibitorsblockdnarepairandradiosensitizenonsmallcelllungcancer
AT hsiehgrace proteasomeinhibitorsblockdnarepairandradiosensitizenonsmallcelllungcancer
AT merzondmitry proteasomeinhibitorsblockdnarepairandradiosensitizenonsmallcelllungcancer
AT ramesederjonathan proteasomeinhibitorsblockdnarepairandradiosensitizenonsmallcelllungcancer
AT chenclarkc proteasomeinhibitorsblockdnarepairandradiosensitizenonsmallcelllungcancer
AT dandreaaland proteasomeinhibitorsblockdnarepairandradiosensitizenonsmallcelllungcancer
AT kozonodavid proteasomeinhibitorsblockdnarepairandradiosensitizenonsmallcelllungcancer